ANI Pharmaceuticals to present Phase 4 SYNCHRONICITY trial data at AAO 2026

ANI Pharmaceuticals says SYNCHRONICITY Phase 4 results for fluocinolone acetonide intravitreal implant in chronic non-infectious posterior uveitis will be presented Oct. 9, 2026, with diabetic macular edema post-hoc NEW DAY analyses planned for an on-demand ePoster.